BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17495601)

  • 1. Lipids in the heart: a source of fuel and a source of toxins.
    Park TS; Yamashita H; Blaner WS; Goldberg IJ
    Curr Opin Lipidol; 2007 Jun; 18(3):277-82. PubMed ID: 17495601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
    Vikramadithyan RK; Hirata K; Yagyu H; Hu Y; Augustus A; Homma S; Goldberg IJ
    J Pharmacol Exp Ther; 2005 May; 313(2):586-93. PubMed ID: 15671204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36.
    Habets DD; Coumans WA; Voshol PJ; den Boer MA; Febbraio M; Bonen A; Glatz JF; Luiken JJ
    Biochem Biophys Res Commun; 2007 Mar; 355(1):204-10. PubMed ID: 17292863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac metabolism and mechanics are altered by genetic loss of lipoprotein triglyceride lipolysis.
    Noh HL; Yamashita H; Goldberg IJ
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):441-4. PubMed ID: 17139480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
    Baranowski M; Blachnio-Zabielska A; Zabielski P; Gorski J
    Arch Biochem Biophys; 2008 Sep; 477(1):86-91. PubMed ID: 18541139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High fat diet induced diabetic cardiomyopathy.
    Dirkx E; Schwenk RW; Glatz JF; Luiken JJ; van Eys GJ
    Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):219-25. PubMed ID: 21571515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase: from gene to obesity.
    Wang H; Eckel RH
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E271-88. PubMed ID: 19318514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver lipid metabolism.
    Nguyen P; Leray V; Diez M; Serisier S; Le Bloc'h J; Siliart B; Dumon H
    J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):272-83. PubMed ID: 18477307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression.
    Vega VA; Anzulovich AC; Varas SM; Bonomi MR; Giménez MS; Oliveros LB
    Nutrition; 2009; 25(7-8):828-38. PubMed ID: 19342198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic modification of the heart: transgenic modification of cardiac lipid and carbohydrate utilization.
    Hartil K; Charron MJ
    J Mol Cell Cardiol; 2005 Oct; 39(4):581-93. PubMed ID: 16140322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid composition of serum, heart, and liver of hereditary myocardiopathic hamsters (BIO 14.6).
    Szollár L; Pucsok J; Szelényi I; Sós J
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():313-20. PubMed ID: 4806972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolism of fatty acids in the healthy myocardium and in ischemia].
    Matiushin IF; Boiarinov GA; Bogdarin IuA
    Vopr Med Khim; 1984; 30(5):2-13. PubMed ID: 6396941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.
    Koonen DP; Jacobs RL; Febbraio M; Young ME; Soltys CL; Ong H; Vance DE; Dyck JR
    Diabetes; 2007 Dec; 56(12):2863-71. PubMed ID: 17728375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD36 expression contributes to age-induced cardiomyopathy in mice.
    Koonen DP; Febbraio M; Bonnet S; Nagendran J; Young ME; Michelakis ED; Dyck JR
    Circulation; 2007 Nov; 116(19):2139-47. PubMed ID: 17967771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits.
    Chabowski A; Zmijewska M; Górski J; Bonen A; Kamiński K; Winnicka MM
    J Physiol Pharmacol; 2007 Mar; 58(1):73-82. PubMed ID: 17440227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.